Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Glucagon orchestrates stress-induced hyperglycaemia.

Harp JB, Yancopoulos GD, Gromada J.

Diabetes Obes Metab. 2016 Jul;18(7):648-53. doi: 10.1111/dom.12668. Review.

2.

Non-invasive cell type selective in vivo monitoring of insulin resistance dynamics.

Paschen M, Moede T, Leibiger B, Jacob S, Bryzgalova G, Leibiger IB, Berggren PO.

Sci Rep. 2016 Feb 22;6:21448. doi: 10.1038/srep21448.

3.

Contrasting effects of afferent and efferent vagal nerve stimulation on insulin secretion and blood glucose regulation.

Meyers EE, Kronemberger A, Lira V, Rahmouni K, Stauss HM.

Physiol Rep. 2016 Feb;4(4). pii: e12718. doi: 10.14814/phy2.12718.

4.

Autophagy deficiency in β cells blunts incretin-induced suppression of glucagon release from α cells.

Kim MJ, Choi OK, Chae KS, Lee H, Chung SS, Ham DS, Kim JW, Yoon KH, Park KS, Jung HS.

Islets. 2015;7(5):e1129096. doi: 10.1080/19382014.2015.1129096.

5.

Angptl4 links α-cell proliferation following glucagon receptor inhibition with adipose tissue triglyceride metabolism.

Ben-Zvi D, Barrandon O, Hadley S, Blum B, Peterson QP, Melton DA.

Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):15498-503. doi: 10.1073/pnas.1513872112.

6.

There is Kisspeptin - And Then There is Kisspeptin.

Hussain MA, Song WJ, Wolfe A.

Trends Endocrinol Metab. 2015 Oct;26(10):564-72. doi: 10.1016/j.tem.2015.07.008. Review.

7.

EphA4 Receptor Forward Signaling Inhibits Glucagon Secretion From α-Cells.

Hutchens T, Piston DW.

Diabetes. 2015 Nov;64(11):3839-51. doi: 10.2337/db15-0488.

8.

The Zinc Transporter Slc30a8/ZnT8 Is Required in a Subpopulation of Pancreatic α-Cells for Hypoglycemia-induced Glucagon Secretion.

Solomou A, Meur G, Bellomo E, Hodson DJ, Tomas A, Li SM, Philippe E, Herrera PL, Magnan C, Rutter GA.

J Biol Chem. 2015 Aug 28;290(35):21432-42. doi: 10.1074/jbc.M115.645291.

9.

A novel insulinotropic mechanism of whole grain-derived γ-oryzanol via the suppression of local dopamine D2 receptor signalling in mouse islet.

Kozuka C, Sunagawa S, Ueda R, Higa M, Ohshiro Y, Tanaka H, Shimizu-Okabe C, Takayama C, Matsushita M, Tsutsui M, Ishiuchi S, Nakata M, Yada T, Miyazaki JI, Oyadomari S, Shimabukuro M, Masuzaki H.

Br J Pharmacol. 2015 Jul 3. doi: 10.1111/bph.13236. [Epub ahead of print]

10.

Metabolomics applied to the pancreatic islet.

Gooding JR, Jensen MV, Newgard CB.

Arch Biochem Biophys. 2016 Jan 1;589:120-30. doi: 10.1016/j.abb.2015.06.013. Review.

11.

Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic β- and α-Cells.

Mohan R, Mao Y, Zhang S, Zhang YW, Xu CR, Gradwohl G, Tang X.

J Biol Chem. 2015 Aug 7;290(32):19955-66. doi: 10.1074/jbc.M115.650705.

12.

High-fat diet feeding significantly attenuates anagliptin-induced regeneration of islets of Langerhans in streptozotocin-induced diabetic mice.

Shinjo T, Nakatsu Y, Iwashita M, Sano T, Sakoda H, Ishihara H, Kushiyama A, Fujishiro M, Nishimura F, Asano T.

Diabetol Metab Syndr. 2015 Jun 2;7:50. doi: 10.1186/s13098-015-0047-y.

13.

miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development.

Latreille M, Herrmanns K, Renwick N, Tuschl T, Malecki MT, McCarthy MI, Owen KR, Rülicke T, Stoffel M.

J Mol Med (Berl). 2015 Oct;93(10):1159-69. doi: 10.1007/s00109-015-1296-9.

14.

Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.

Titchenell PM, Chu Q, Monks BR, Birnbaum MJ.

Nat Commun. 2015 May 12;6:7078. doi: 10.1038/ncomms8078.

15.

Insulin and Leptin Signaling Interact in the Mouse Kiss1 Neuron during the Peripubertal Period.

Qiu X, Dao H, Wang M, Heston A, Garcia KM, Sangal A, Dowling AR, Faulkner LD, Molitor SC, Elias CF, Hill JW.

PLoS One. 2015 May 6;10(5):e0121974. doi: 10.1371/journal.pone.0121974.

16.

LKB1 and AMPKα1 are required in pancreatic alpha cells for the normal regulation of glucagon secretion and responses to hypoglycemia.

Sun G, da Silva Xavier G, Gorman T, Priest C, Solomou A, Hodson DJ, Foretz M, Viollet B, Herrera PL, Parker H, Reimann F, Gribble FM, Migrenne S, Magnan C, Marley A, Rutter GA.

Mol Metab. 2015 Jan 31;4(4):277-86. doi: 10.1016/j.molmet.2015.01.006.

17.

Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice.

So WY, Cheng Q, Xu A, Lam KS, Leung PS.

Cell Death Dis. 2015 Mar 26;6:e1707. doi: 10.1038/cddis.2015.80.

18.

Pancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the Block.

Moon JS, Won KC.

Diabetes Metab J. 2015 Feb;39(1):1-9. doi: 10.4093/dmj.2015.39.1.1. Review.

19.

Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp.

Farmer TD, Jenkins EC, O'Brien TP, McCoy GA, Havlik AE, Nass ER, Nicholson WE, Printz RL, Shiota M.

Am J Physiol Endocrinol Metab. 2015 Feb 1;308(3):E206-22. doi: 10.1152/ajpendo.00406.2014.

20.

Additive effects of miglitol and anagliptin on insulin-treated type 2 diabetes mellitus: a case study.

Kishimoto M, Noda M.

Clin Drug Investig. 2015 Feb;35(2):141-7. doi: 10.1007/s40261-014-0260-8.

Items per page

Supplemental Content

Support Center